Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Vasiliki Leventaki MD

Vasiliki Leventaki MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Administration
Program: Pediatrics


Publications (46)

  • MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. (Wang S, Oh DY, Leventaki V, Drakos E, Zhang R, Sahin AA, Resetkova E, Edgerton ME, Wu W, Claret FX) Cancer Lett 2019 Nov 28;465:12-23 PMID: 31473252 SCOPUS ID: 2-s2.0-85071611443 09/02/2019    
  • AP-1 Transcription Factors as Regulators of Immune Responses in Cancer. (Atsaves V, Leventaki V, Rassidakis GZ, Claret FX) Cancers (Basel) 2019 Jul 23;11(7) PMID: 31340499 PMCID: PMC6678392 07/26/2019    
  • Germline deletion of in familial acute lymphoblastic leukemia. (Rampersaud E, Ziegler DS, Iacobucci I, Payne-Turner D, Churchman ML, Schrader KA, Joseph V, Offit K, Tucker K, Sutton R, Warby M, Chenevix-Trench G, Huntsman DG, Tsoli M, Mead RS, Qu C, Leventaki V, Wu G, Mullighan CG) Blood Adv 2019 Apr 09;3(7):1039-1046 PMID: 30940639 PMCID: PMC6457220 SCOPUS ID: 2-s2.0-85068308046 04/04/2019       1 Citation
  • Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib. (Graetz D, Crews KR, Azzato EM, Singh RK, Raimondi S, Mason J, Valentine M, Mullighan CG, Holland A, Inaba H, Leventaki V) Haematologica 2019 May;104(5):e218-e221 PMID: 30819904 PMCID: PMC6518893 SCOPUS ID: 2-s2.0-85065466454 03/02/2019    
  • Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis. (Bjornard KL, Leventaki V, Nichols KE, Sandlund JT, Prockop S, Ehrhardt MJ) Pediatr Blood Cancer 2018 12;65(12):e27415 PMID: 30151967 SCOPUS ID: 2-s2.0-85052806933 08/29/2018    
  • Sarcoid-like granulomatosis in a patient receiving anti-TNF╬▒ for psoriasis. (Leventaki V, Flerlage J) Am J Hematol 2018 05;93(5):722-723 PMID: 29274117 SCOPUS ID: 2-s2.0-85042445589 12/24/2017    
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature T-Cell Malignancies. (Wei EX, Leventaki V, Choi JK, Raimondi SC, Azzato EM, Shurtleff SA, Ong MG, Veillon DM, Cotelingam JD, Shackelford RE) Case Rep Hematol 2017;2017:5873015 PMID: 29147589 PMCID: PMC5632927 11/18/2017    
  • PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma. (Atsaves V, Tsesmetzis N, Chioureas D, Kis L, Leventaki V, Drakos E, Panaretakis T, Grander D, Medeiros LJ, Young KH, Rassidakis GZ) Leukemia 2017 07;31(7):1633-1637 PMID: 28344319 SCOPUS ID: 2-s2.0-85017521489 03/28/2017       41 Citations
  • Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex. (Palacios G, Shaw TI, Li Y, Singh RK, Valentine M, Sandlund JT, Lim MS, Mullighan CG, Leventaki V) Leukemia 2017 03;31(3):743-747 PMID: 27840423 PMCID: PMC5639880 SCOPUS ID: 2-s2.0-85008316381 11/15/2016       3 Citations
  • Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis. (Helton KJ, Maron G, Mamcarz E, Leventaki V, Patay Z, Sadighi Z) Bone Marrow Transplant 2016 11;51(11):1533-1536 PMID: 27348541 SCOPUS ID: 2-s2.0-84976259432 11/03/2016       3 Citations
  • Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression. (Pan Y, Wang S, Su B, Zhou F, Zhang R, Xu T, Zhang R, Leventaki V, Drakos E, Liu W, Claret FX) Oncogene 2017 02 23;36(8):1069-1079 PMID: 27524414 PMCID: PMC5311075 SCOPUS ID: 2-s2.0-84982123817 08/16/2016       16 Citations
  • Hemophagocytic Lymphohistiocytosis and Progressive Disseminated Histoplasmosis. (Ferguson-Paul K, Mangum S, Porter A, Leventaki V, Campbell P, Wolf J) Emerg Infect Dis 2016 06;22(6):1119-21 PMID: 27191972 PMCID: PMC4880106 SCOPUS ID: 2-s2.0-84969262674 05/19/2016       6 Citations
  • Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy. (Ok CY, Leventaki V, Wang SA, Dinardo C, Medeiros LJ, Konoplev S) Am J Clin Pathol 2016 Feb;145(2):271-6 PMID: 26800764 PMCID: PMC4934016 SCOPUS ID: 2-s2.0-84959421914 01/24/2016       7 Citations
  • Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism. (Atsaves V, Zhang R, Ruder D, Pan Y, Leventaki V, Rassidakis GZ, Claret FX) Leukemia 2015 Nov;29(11):2162-72 PMID: 25987255 PMCID: PMC4633353 SCOPUS ID: 2-s2.0-84946499946 05/20/2015       9 Citations
  • Tumors of lymphoid and hematopoietic tissues (Leventaki V, Khoury JD, Voss SD) Pediatric Malignancies: Pathology and Imaging 1 January 2015:103-149 SCOPUS ID: 2-s2.0-84944529107 01/01/2015    
  • The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma. (Atsaves V, Lekakis L, Drakos E, Leventaki V, Ghaderi M, Baltatzis GE, Chioureas D, Jones D, Feretzaki M, Liakou C, Panayiotidis P, Gorgoulis V, Patsouris E, Medeiros LJ, Claret FX, Rassidakis GZ) Br J Haematol 2014 Nov;167(4):514-23 PMID: 25145835 SCOPUS ID: 2-s2.0-84915795235 08/26/2014       18 Citations
  • c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma. (Leventaki V, Drakos E, Karanikou M, Psatha K, Lin P, Schlette E, Eliopoulos A, Vassilakopoulos TP, Papadaki H, Patsouris E, Medeiros LJ, Rassidakis GZ) Hum Pathol 2014 Mar;45(3):565-72 PMID: 24457077 SCOPUS ID: 2-s2.0-84894071207 01/25/2014       15 Citations
  • Indolent peripheral T-cell lymphoma involving the gastrointestinal tract. (Leventaki V, Manning JT Jr, Luthra R, Mehta P, Oki Y, Romaguera JE, Medeiros LJ, Vega F) Hum Pathol 2014 Feb;45(2):421-6 PMID: 24439229 SCOPUS ID: 2-s2.0-84892752498 01/21/2014       12 Citations
  • Lymphoid malignancies: Molecular diagnostics (Leventaki V, Vega F) Molecular Genetic Pathology: Second Edition 1 March 2013;9781461448006:887-928 SCOPUS ID: 2-s2.0-84929901778 03/01/2013    
  • Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype. (Kunkalla K, Liu Y, Qu C, Leventaki V, Agarwal NK, Singh RR, Vega F) Ann Hematol 2013 Jun;92(6):777-87 PMID: 23370596 PMCID: PMC3648611 SCOPUS ID: 2-s2.0-84877790356 02/02/2013       9 Citations
  • TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases. (Leventaki V, Rodic V, Tripp SR, Bayerl MG, Perkins SL, Barnette P, Schiffman JD, Miles RR) Br J Haematol 2012 Sep;158(6):763-71 PMID: 22845047 SCOPUS ID: 2-s2.0-84865564381 08/01/2012       15 Citations
  • Extracavitary/solid variant of primary effusion lymphoma. (Kim Y, Leventaki V, Bhaijee F, Jackson CC, Medeiros LJ, Vega F) Ann Diagn Pathol 2012 Dec;16(6):441-6 PMID: 22497739 SCOPUS ID: 2-s2.0-84868517175 04/14/2012       34 Citations
  • Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. (Ohanian M, Leventaki V, Verstovsek S, Estrov Z, Lin P, Yin C, Kantarjian H, Huh Y, Ravandi F) Leuk Lymphoma 2012 Sep;53(9):1839-41 PMID: 22303899 PMCID: PMC4120044 SCOPUS ID: 2-s2.0-84865033356 02/07/2012       4 Citations
  • Expression patterns of endothelin-1 and its receptors in colorectal cancer. (Liakou P, Tepetes K, Germenis A, Leventaki V, Atsaves V, Patsouris E, Roidis N, Hatzitheophilou K, Rassidakis GZ) J Surg Oncol 2012 Jun 01;105(7):643-9 PMID: 22213082 SCOPUS ID: 2-s2.0-84859925476 01/04/2012       11 Citations
  • Yolk sac tumor of the thyroid gland: a case report. (Furtado LV, Leventaki V, Layfield LJ, Lowichik A, Muntz HR, Pysher TJ) Pediatr Dev Pathol 2011 Nov-Dec;14(6):475-9 PMID: 21793665 SCOPUS ID: 2-s2.0-84856381780 07/29/2011       12 Citations
  • Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas. (Drakos E, Leventaki V, Atsaves V, Schlette EJ, Lin P, Vega F, Miranda RN, Claret FX, Medeiros LJ, Rassidakis GZ) Hum Pathol 2011 Aug;42(8):1117-24 PMID: 21315423 PMCID: PMC4089890 SCOPUS ID: 2-s2.0-79960429920 02/15/2011       8 Citations
  • mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells. (Chen W, Drakos E, Grammatikakis I, Schlette EJ, Li J, Leventaki V, Staikou-Drakopoulou E, Patsouris E, Panayiotidis P, Medeiros LJ, Rassidakis GZ) Mol Cancer 2010 Nov 10;9:292 PMID: 21067588 PMCID: PMC2993677 SCOPUS ID: 2-s2.0-78149237281 11/12/2010       40 Citations
  • Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. (Tian L, Peng G, Parant JM, Leventaki V, Drakos E, Zhang Q, Parker-Thornburg J, Shackleford TJ, Dai H, Lin SY, Lozano G, Rassidakis GZ, Claret FX) Oncogene 2010 Nov 18;29(46):6125-37 PMID: 20802511 PMCID: PMC3495558 SCOPUS ID: 2-s2.0-78650193203 08/31/2010       38 Citations
  • Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant. (Drakos E, Rassidakis GZ, Leventaki V, Cotta CV, Vega F, Medeiros LJ) Am J Surg Pathol 2009 Nov;33(11):1725-31 PMID: 19730363 SCOPUS ID: 2-s2.0-70350441394 09/05/2009       4 Citations
  • Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine. (Inamdar KV, Romaguera JE, Drakos E, Knoblock RJ, Garcia M, Leventaki V, Medeiros LJ, Rassidakis GZ) Cancer 2009 Oct 15;115(20):4727-36 PMID: 19708031 SCOPUS ID: 2-s2.0-70350114434 08/27/2009       16 Citations
  • Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. (Chen W, Konoplev S, Medeiros LJ, Koeppen H, Leventaki V, Vadhan-Raj S, Jones D, Kantarjian HM, Falini B, Bueso-Ramos CE) Cancer 2009 Dec 01;115(23):5481-9 PMID: 19672946 PMCID: PMC3378048 SCOPUS ID: 2-s2.0-72249099452 08/13/2009       41 Citations
  • Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. (Drakos E, Atsaves V, Li J, Leventaki V, Andreeff M, Medeiros LJ, Rassidakis GZ) Leukemia 2009 Apr;23(4):784-90 PMID: 19225536 SCOPUS ID: 2-s2.0-64849110053 02/20/2009       40 Citations
  • The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. (Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D, Medeiros LJ, Rassidakis GZ) Cancer 2008 Feb 01;112(3):552-61 PMID: 18085637 SCOPUS ID: 2-s2.0-38749093745 12/19/2007       14 Citations
  • Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. (Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, Konopleva M, Andreeff M, Rassidakis GZ) Clin Cancer Res 2007 Jun 01;13(11):3380-7 PMID: 17545546 SCOPUS ID: 2-s2.0-34250669968 06/05/2007       70 Citations
  • NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. (Leventaki V, Drakos E, Medeiros LJ, Lim MS, Elenitoba-Johnson KS, Claret FX, Rassidakis GZ) Blood 2007 Sep 01;110(5):1621-30 PMID: 17416736 SCOPUS ID: 2-s2.0-34548821219 04/10/2007       62 Citations
  • c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. (Drakos E, Leventaki V, Schlette EJ, Jones D, Lin P, Medeiros LJ, Rassidakis GZ) Am J Surg Pathol 2007 Mar;31(3):447-53 PMID: 17325487 SCOPUS ID: 2-s2.0-34247564713 02/28/2007       24 Citations
  • Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas. (Drakos E, Rassidakis GZ, Leventaki V, Guo W, Medeiros LJ, Nagarajan L) Hum Pathol 2007 Mar;38(3):500-7 PMID: 17303500 SCOPUS ID: 2-s2.0-33846886513 02/17/2007       4 Citations
  • Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. (Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ) Am J Pathol 2006 Dec;169(6):2171-80 PMID: 17148679 PMCID: PMC1762462 SCOPUS ID: 2-s2.0-34248647440 12/07/2006       101 Citations
  • Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. (Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ) Cancer Res 2006 Jul 01;66(13):6589-97 PMID: 16818631 PMCID: PMC4839264 SCOPUS ID: 2-s2.0-33746118057 07/05/2006       159 Citations
  • c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma. (Oyarzo MP, Medeiros LJ, Atwell C, Feretzaki M, Leventaki V, Drakos E, Amin HM, Rassidakis GZ) Blood 2006 Mar 15;107(6):2544-7 PMID: 16304056 SCOPUS ID: 2-s2.0-33644774474 11/24/2005       29 Citations
  • Re: Rust et al. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol 2005;206:445-450. (Lai R, Leventaki V, Rassidakis GZ) J Pathol 2005 Nov;207(3):372-3; author reply 374-5 PMID: 16161018 SCOPUS ID: 2-s2.0-27644476440 09/15/2005    
  • Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. (Amin HM, McDonnell TJ, Ma Y, Lin Q, Fujio Y, Kunisada K, Leventaki V, Das P, Rassidakis GZ, Cutler C, Medeiros LJ, Lai R) Oncogene 2004 Jul 15;23(32):5426-34 PMID: 15184887 SCOPUS ID: 2-s2.0-3843062504 06/09/2004       136 Citations
  • Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. (Khoury JD, Medeiros LJ, Rassidakis GZ, Yared MA, Tsioli P, Leventaki V, Schmitt-Graeff A, Herling M, Amin HM, Lai R) Clin Cancer Res 2003 Sep 01;9(10 Pt 1):3692-9 PMID: 14506160 SCOPUS ID: 2-s2.0-12444287592 09/25/2003       84 Citations
  • Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. (Amin HM, Medeiros LJ, Ma Y, Feretzaki M, Das P, Leventaki V, Rassidakis GZ, O'Connor SL, McDonnell TJ, Lai R) Oncogene 2003 Aug 21;22(35):5399-407 PMID: 12934099 SCOPUS ID: 2-s2.0-0042335770 08/23/2003       106 Citations
  • Characterization of 4 mantle cell lymphoma cell lines. (Amin HM, McDonnell TJ, Medeiros LJ, Rassidakis GZ, Leventaki V, O'Connor SL, Keating MJ, Lai R) Arch Pathol Lab Med 2003 Apr;127(4):424-31 PMID: 12683869 SCOPUS ID: 2-s2.0-0037391344 04/10/2003       101 Citations
  • Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours. (Lai R, Rassidakis GZ, Medeiros LJ, Leventaki V, Keating M, McDonnell TJ) J Pathol 2003 Jan;199(1):84-9 PMID: 12474230 SCOPUS ID: 2-s2.0-0037220899 12/11/2002       39 Citations
  • Last update: 11/11/2019
    jenkins-FCD Prod-409 d1e206b0be345926047b0d9c353c78a4cce4058b